Screening

During this session, Dr. Lopata discussed federal/HRSA investments focused on improving the health outcomes for and reducing health disparities among maternal and child health populations. More specifically, Dr. Lopata discussed the multiple programs/interventions funded by HRSA that together work (along with federal, state, regional, and local partners) to improve the prevention, screening, and treatment of opioid use disorder during pregnancy and Neonatal Abstinence Syndrome in the United States.

This updated (March 2020) TIP is intended to provide addiction counselors and other providers, supervisors, and administrators with the latest science in the screening, assessment, diagnosis, and management of co-occurring disorders (CODs).

NIDAMED’s mission is to develop science-based resources for health professionals and those in training about screening, addressing, and treating addiction.

The Opioid Response Network is making available a new dental curriculum on SBIRT (screening, brief intervention and referral to treatment), an evidence-based approach to managing patients with or at risk of developing a substance use disorder (SUD). The curriculum was developed for dentists by the ORN grant through a collaboration with the American Academy of Addiction Psychiatry and the Division on Substance Use Disorders, Columbia University Irving Medical Center/NYSPI.

This resource provides a summary of HIV risk assessment, screening tests, screening intervals, and treatment and interventions for both adolescents and adults and pregnant persons.

To identify Finnegan Neonatal Abstinence Scoring Tool tems independently associated with the decision to use pharmacologic therapy and to simplify the FNAST while minimizing loss of information for the treatment decision.

SBIRT is an integrated, public health approach to the delivery of early intervention and treatment services for persons with substance use disorders and those at risk of developing these disorders.